Bankruptcies
Filter News
Found 358 articles
-
AirXpanders® Announces Reduction in Force and Plan to Cease Operations
7/17/2019
AirXpanders, Inc., a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, announced that the Company has reduced its workforce and plans to cease operations.
-
Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)
7/16/2019
Biofourmis' innovative technology to measure patient-centric endpoints to inform future drug development
-
Joerns Healthcare Seeking To Eliminate Debt With Restructuring Plan
6/25/2019
The company is seeking court approval of a restructuring plan that is supported by the majority of its lenders and noteholders.
-
The bankruptcy announcement comes weeks after Insys founder John Kapoor and four former executives were found guilty of orchestrating a kickback scheme to boost sales of its powerful opioid Subsys. -
Insys owes more than $240 million in legal-related fees but the company only has about $87 million in available cash.
-
Anka Behavioral Health, Inc. Announces Wind Down of Residential Treatment Programs as Company Enters Chapter 11
5/1/2019
Anka Behavioral Health, Inc. announced that it has begun the orderly wind down of all of its residential treatment programs and has initiated proceedings under chapter 11 of the United States Bankruptcy Code in the Northern District of California.
-
The company announced it is seeking authorization to pursue both an auction and sale under the U.S. Bankruptcy Code. -
Loopback Analytics and The University of Vermont Medical Center Partner on Specialty Pharmacy to Improve Patient Outcomes
3/21/2019
Loopback Analytics announced it has partnered with The University of Vermont Medical Center to help advance the network's specialty and ambulatory pharmacy services.
-
Shares of Insys plunged more than 25 percent in trading Wednesday after the company said in a filing with the U.S. Securities and Exchange Commission that it could soon run out of revenue and may have to resort to liquidating its assets.
-
As Purdue Pharma grapples with multiple lawsuits over its OxyContin pain killer, there are reports that the drugmaker is exploring bankruptcy as a legal defense mechanism. -
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
3/1/2019
Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, confirmed that the previously announced agreement with Bausch Health Companies Inc.
-
Laser Spine Institute to Close its Doors, Citing Lack of Financing for Continuing Operations
3/1/2019
Company is notifying patients and working with local area competitors to shift scheduled surgeries
-
The season surrounding Valentine’s Day brings out the love in many people, but for two pharma companies, this year was a year of heartbreak. California-based Aradigm Corporation and New Jersey-based Immune Pharmaceuticals both filed Chapter 11. -
Aradigm Announces Plans for Reorganization Under Chapter 11 of the U.S. Bankruptcy Code
2/16/2019
Aradigm Corporation has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda County Court District to facilitate the sale of its assets.
-
Your Feedback Matters! Topics in 2019
1/15/2019
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about. -
Valeo Pharma and Zambon announce the approval of Onstryv® (safinamide) for Canada
1/15/2019
Valeo Pharma and Zambon previously announced a partnership which grants Valeo Pharma exclusive Canadian rights to commercialize safinamide (known as Onstryv® in Canada and Xadago® in the rest of the world.)
-
In writing literally hundreds of stories this year, two BioSpace writers, Alex Keown and Mark Terry, found certain stories particularly intriguing or impactful. Some of those were such big topics that they were covered over a series of stories. Looking back at 2018, here are their Top 10.
-
Theranos fit in with the opaque culture of Silicon Valley, which allowed it to thrive and amass a fortune without delivering anything, book argues. -
BioAmber Provides Update on Liquidation Process Under the Companies Creditors' Arrangement Act, R.S.C. 1985, c. C-36
10/25/2018
PricewaterhouseCoopers Inc., LIT, in its capacity as the court-appointed Monitor (in such capacity, the "Monitor") of BioAmber Inc. (OTCPK: BIOAQ), BioAmber Canada Inc., and BioAmber Sarnia Inc. (collectively, the "Company") in their proceedings under the Companies Creditors' Arrangement Act, R.S.C. 1985, c. C-36, as amended (the "CCAA"), provides the following update on the Company's liquidation process.
-
KPC Health Announces New Partnership with HealthCare Partners
9/20/2018
New Partnership Will Improve Orange County’s Healthcare Services